According to AIER Eye Hospital's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 34.8628. At the end of 2024 the company had a P/E ratio of 35.5.
Year | P/E ratio | Change |
---|---|---|
2024 | 35.5 | -18.27% |
2023 | 43.4 | -49.32% |
2022 | 85.7 | -14.95% |
2021 | 101 | -25.04% |
2020 | 134 | 101.34% |
2019 | 66.7 | 49.46% |
2018 | 44.6 | -8.73% |
2017 | 48.9 | 17.65% |
2016 | 41.6 | -27.51% |
2015 | 57.4 | 30.77% |
2014 | 43.9 | -6.74% |
2013 | 47.0 | 53.31% |
2012 | 30.7 | -36.1% |
2011 | 48.0 | -34.86% |
2010 | 73.7 | 75.09% |
2009 | 42.1 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.